Cunningham et al., 1969 - Google Patents
Treatment of advanced cancer with active immunizationCunningham et al., 1969
View PDF- Document ID
- 6596232565380766999
- Author
- Cunningham T
- Olson K
- Laffin R
- Horton J
- Sullivan J
- Publication year
- Publication venue
- Cancer
External Links
Snippet
Forty‐two patients with advanced cancer of various types were actively immunized with autologous tumor coupled to rabbit gamma‐globulin. Only one of the 36 evaluable patients had objective evidence of tumor regression. A partial immunologic survey showed no …
- 201000011510 cancer 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cunningham et al. | Treatment of advanced cancer with active immunization | |
Golub et al. | A modification of the hemolytic plaque assay for use with protein antigens | |
Hoffmann et al. | Regulation of the immune response: II. Qualitative and quantitative differences between thymus-and bone marrow-derived lymphocytes in the recognition of antigen | |
Pritchard et al. | Immune responses in congenitally thymus-less mice. II. Quantitative studies of serum immunoglobulins, the antibody response to sheep erythrocytes, and the effect of thymus allografting | |
Pierce et al. | Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses. | |
Goidl et al. | The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody | |
Braun et al. | Rabbit antibodies to streptococcal carbohydrates: influence of primary and secondary immunization and of possible genetic factors on the antibody response | |
Green et al. | HAPTEN CARRIER RELATIONSHIPS IN THE DNP-PLL· FOREIGN ALBUMIN COMPLEX SYSTEM: INDUCTION OF TOLERANCE AND STIMULATION OF CELLS IN VITRO | |
BOREL | Induction of immunological tolerance by a hapten (DNP) bound to a non-immunogenic protein carrier | |
Kappler et al. | Regulation of the immune response: I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes | |
Klinman et al. | The stimulation of splenic foci in vitro | |
Penny et al. | Repeated stimulation of the reticuloendothelial system and the development of plasma-cell dyscrasias | |
Rozee et al. | Effect of priming on interferon inhibition of Con A induced spleen cell blastogenesis | |
Hamaoka et al. | Antibody production in mice: IV. The suppressive effect of anti-hapten and anti-carrier antibodies on the recognition of hapten-carrier conjugate in the secondary response | |
Klinman | The secondary immune response to a hapten in vitro: antigen concentration and the carrier effect | |
Halliday et al. | Some factors affecting the secondary immune response in tissue cultures containing hydrocortisone | |
Bluestein et al. | SPECIFIC IMMUNE RESPONSE GENES OF THE GUINEA PIG: V. Influence of the GA and GT Immune Response Genes on the Specificity of Cellular and Humoral Immune Responses to a Terpolymer of l-Glutamic Acid, l-Alanine, and l-Tyrosine | |
Wu et al. | ANTIGENIC PROMOTION: Increase in Hapten-Specific Plaque-Forming Cells after Preinjection with Structurally Unrelated Macromolecules | |
Senyk et al. | The immune response to glucagon in conjugated form | |
Kato | Immunochemical properties of anti-cord factor antibody | |
Baker et al. | Ribosomes of acid-fast bacilli: immunogenicity, serology, and in vitro correlates of delayed hypersensitivity | |
Fauci et al. | Suppression of Antibody Synthesis: I. Evidence for a Circulating Inhibitor of Antibody Synthesis Demonstrable at the Cellular Level | |
Macario et al. | Sequential changes and persistence of antibody molecules during the immune response with special reference to the binding properties of the antigen-combining site | |
Miller Jr | Experimental observations on the antigenic potency of H. pertussis extracts | |
Roe et al. | Thalidomide and neoplasia |